Funding for this research was provided by:
Naviswiss AG
Article History
Received: 17 July 2023
Accepted: 12 December 2023
First Online: 8 January 2024
Declarations
:
: Ethical approval for the study was obtained from the Ramsay Health Care Queensland Human Research Ethics Committee (HREC Reference 20/08), and the study was registered with the Australian New Zealand Clinical Trials Registry (ACTRN12620000873921).
: Not applicable.
: C.J.S. and M.F. are employed by EBM Analytics, and were contracted by Naviwsiss AG to assist with completion of a protocol manuscript and data analysis for this and another study of the same device; C.J.S. is a shareholder in EBM Analytics; T.S. is employed by Medivation, and was contracted by Naviswiss AG to assist with the completion of the current study; T.S. additionally declares stock in Naviswiss AG; D.L. declares stock in and an unpaid consultancy with Naviwswiss AG; D.L. is the member of <i>Arthroplasty</i> Editorial Board, and all authors were not involved in the journal’s review or decisions related to this manuscript.